C4 Therapeutics Stock (NASDAQ: CCCC) stock price, news, charts, stock research, profile.
Open | $6.44 |
Close | - |
Volume / Avg. | 379.16K / 1.60M |
Day Range | $5.97 - $6.47 |
52 Wk Range | 1.06 - 11.88 |
Market Cap | $423.84M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 20.59% |
Days to Cover | 12.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Other companies in C4 Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
C4 Therapeutics has a consensus price target of $16.18.
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $6.16 last updated September 23, 2024 at 1:59 PM EDT.
There are no upcoming dividends for C4 Therapeutics.
C4 Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for C4 Therapeutics.
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.